| ORIGINAL ARTICLE |
|
| Year : 2006 | Volume
: 1
| Issue : 2 | Page : 67-70 |
|
|
Circulating LTB4 and Eotaxin-1 in stable asthmatics on inhaled corticosteroids and long-acting β 2-agonists
Mohammed A Alzoghaibi1, Ahmed S BaHammam2
1 Departments of Physiology and Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia
2 Respiratory Unit, Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia
Correspondence Address:
Ahmed S BaHammam
College of Medicine, Respiratory Unit, Department of Medicine, King Saud University,
Saudi Arabia
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1817-1737.27104
|
|
|
BACKGROUND : Leukotrienes B4 (LTB4) and eotaxin-1 are thought to play a pivotal role in the pathogenesis of asthma. This study investigates the plasma levels of LTB4 and eotaxin-1 in symptom-free asthmatics on inhaled corticosteroids (ICS) and long-acting β2 (LABA) .
MATERIALS AND METHODS : Twenty asthmatic patients treated with ICS and LABA for 3 months and 17 matched healthy subjects were recruited. LTB4 and eotaxin-1 were measured in the serum by a specific enzyme immunoassay kit.
RESULTS : Treatment resulted in significant improvement in FEV1 and disappearance of symptoms. LTB4 levels were significantly lower in the treated asthmatics compared to the healthy subjects (19.17 ± 0.8 pg/ml versus 23.34 ± 0.82 pg/ml respectively, P <0.001). However, there was no significant difference in the levels of eotaxin-1 between healthy subjects and asthmatic patients.
CONCLUSION : Asthmatics treated with ICS and LABA showed significantly lower levels of LTB4 compared to healthy subjects. Regular use of inhaled corticosteroids and long-acting β2 may help in controlling the inflammatory process in asthma. Further studies are needed to confirm these findings and assess the association between clinical and physiological parameters and circulating chemokines and cytokines. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
